Sensus Healthcare, Inc. is a medical device company, which engages in the provision of treatment for both oncological and non-oncological skin conditions. The company is headquartered in Boca Raton, Florida and currently employs 35 full-time employees. The company went IPO on 2016-06-03. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
Follow-Up Questions
Sensus Healthcare Inc (SRTS)'in P/E oranı nedir?
Sensus Healthcare Inc 'in P/E oranı 7.7538 'dir
Sensus Healthcare Inc 'in CEO'su kimdir?
Mr. Joseph Sardano 2010 'den beri şirketle birlikte olan Sensus Healthcare Inc 'in Chairman of the Board 'ıdır.
SRTS hissesinin fiyat performansı nasıl?
SRTS 'in mevcut fiyatı $3.1 'dir, son işlem günde 1.27% decreased etti.
Sensus Healthcare Inc için ana iş temaları veya sektörler nelerdir?
Sensus Healthcare Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Wall Street analistlerine göre, 7 analist Sensus Healthcare Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 8 al, 1 tut, 0 sat ve 2 güçlü sat içermektedir
